Development of a method for magnetic labeling of platelets

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 5, 2012, Pages 537-544

  Aurich, Konstanze ^a   Spoerl, Mark Christopher ^a   Fürll, Birgitt ^a   Sietmann, Rabea ^b   Greinacher, Andreas ^a   Hosten, Norbert ^a   Weitschies, Werner ^b  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Cell tracking; Magnetic resonance imaging; Platelet labeling; Superparamagnetic iron oxide nanoparticles

Indexed keywords

ATOMIC ABSORPTION SPECTROSCOPY; BINDING AGENT; BLEEDING DISORDER; CELL LABELING; CELL TRACKING; CLINICAL APPLICATION; EX-VIVO; IN-VITRO; IN-VIVO; IRON CONCENTRATIONS; IRON NANOPARTICLES; LABELING METHODS; MAGNETIC LABELING; MAGNETIC RESONANCE TOMOGRAPHY; MYOCARDIAL INFARCTION; NONRADIOACTIVE; PLATELET CONCENTRATES; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC NANOPARTICLES; SUPERPARAMAGNETICS; TRANSFUSION MEDICINES;

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; MAGNETIC RESONANCE IMAGING; MOLECULAR BIOLOGY; SUPERPARAMAGNETISM; TRANSMISSION ELECTRON MICROSCOPY;

PLATELETS;

FERUCARBOTRAN; FERUCARBOTRAN SUPERPARAMAGNETIC NANOPARTICLE; FLUORESCENT DYE; IRON; MAGNETIC NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL FRACTIONATION; CELL LABELING; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG UPTAKE; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MAGNETISM; NUCLEAR MAGNETIC RESONANCE IMAGING; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; TRANSMISSION ELECTRON MICROSCOPY;

BLOOD PLATELETS; CELL TRACKING; DEXTRANS; ENDOCYTOSIS; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; STAINING AND LABELING;

EID: 84862684329     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.09.008     Document Type: Article

References (38)

1. Michelson A.D. Platelet function testing in cardiovascular diseases. Circulation 2004, 110:E489-E493.
2. Stroncek D.F., Rebulla P. Transfusion medicine 2 - platelet transfusions. Lancet 2007, 370:427-438.
3. Taylor H.L., Whitley P., Heaton A. A historical perspective on platelet radiolabeling techniques. Transfusion 2006, 46:53S-58S.
4. Semple J.W. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Reviews 2002, 16:9-12.
5. Greinacher A., Warkentin T.E. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res 2006, 118:165-176.
6. Vassallo R.R., Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol 2006, 13:323-330.
7. Heilmann E., Friese P., Anderson S., et al. Biotinylated platelets - a new approach to the measurement of platelet life-span. Br J Haematol 1993, 85:729-735.
8. van der Meer P.F., Tomson B., Brand A. In vivo tracking of transfused platelets for recovery and survival studies: an appraisal of labeling methods. Transfus Apher Sci 2010, 42:53-61.
9. Warner J.B., Bruin E.J., Hannig H., et al. Use of sequence variation in three highly variable regions of the mitochondrial DNA for the discrimination of allogeneic platelets. Transfusion 2006, 46:554-561. Erratum in 46:1461-2.
10. Hughes D.L., Evans G., Metcalfe P., Goodall A.H., Williamson L.M. Tracking and characterisation of transfused platelets by two colour, whole blood flow cytometry. Br J Haematol 2005, 130:791-794.
11. Kresse M., Wagner S., Pfefferer D., Lawaczeck R., Elste V., Semmler W. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn Reson Med 1998, 40:236-242.
12. Weissleder R., Moore A., Mahmood U., et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000, 6:351-355.
13. Wang Z.J., Boddington S., Wendland M., Meier R., Corot C., Daldrup-Link H. MR imaging of ovarian tumors using folate-receptor-targeted contrast agents. Pediatr Radiol 2008, 38:529-537.
14. Chen T.J., Cheng T.H., Chen C.Y., et al. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. J Biol Inorg Chem 2009, 14:253-260.
15. Weissleder R., Lee A.S., Khaw B.A., Shen T., Brady T.J. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 1992, 182:381-385.
16. Tiefenauer L.X., Tschirky A., Kuhne G., Andres R.Y. In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI. Magn Reson Imaging 1996, 14:391-402.
17. Serda R.E., Adolphi N.L., Bisoffi M., Sillerud L.O. Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Mol Imaging 2007, 6:277-288.
18. Partlow K.C., Chen J., Brant J.A., et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb J 2007, 21:1647-1654.
19. von Zur Muhlen C., von Elverfeldt D., Choudhury R.P., et al. Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths. Mol Imaging 2008, 7:59-67.
20. McAteer M.A., Schneider J.E., Ali Z.A., et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol 2008, 28:77-83.
21. von Zur Muhlen C., Peter K., Ali Z.A., et al. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa. J Vasc Res 2009, 46:6-14.
22. Aurich K., Glöckl G., Romanus E., Weber P., Nagel S., Weitschies W. Magneto-optical relaxation measurements for the characterization of biomolecular interactions. J Phys Condens Matter 2006, 18:2847-2863.
23. Sahlin S., Hed J., Rundquist I. Differentiation between attached and ingested immune-complexes by a fluorescence quenching cytofluorometric assay. J Immunol Methods 1983, 60:115-124.
24. Nuutila J., Lilius E.M. Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells. Cytometry Part A 2005, 65A:93-102.
25. White J.G. The morphology of platelet function. Measurement of platelet function 2011, 1-25. Churchill Livingstone, New York. 1st ed. L.A. Harker, T.S. Zimmerman (Eds.).
26. Mendis D., Ginon I., Louis H., McGregor J.L., Poston R.N. Cell biotinylation provides a sensitive and effective detection technique for cellular adhesion assays: comparison with existing methods. J Immunol Methods 2001, 253:57-68.
27. White J.G., Clawson C.C. Effects of large latex particle uptake on the surface connected canalicular system of blood-platelets - a freeze-fracture and cytochemical study. Ultrastruct Pathol 1981, 2:277-287.
28. White J.G., Escolar G. The blood-platelet open canalicular system - a 2-way street. Eur J Cell Biol 1991, 56:233-242.
29. White J.G. Platelets are covercytes, not phagocytes: Uptake of bacteria involves channels of the open canalicular system. Platelets 2005, 16:121-131.
30. Oldenburg A.L., Gallippi C.M., Tsui F., et al. Magnetic and contrast properties of labeled platelets for magnetomotive optical coherence tomography. Biophys J 2010, 99:2374-2383.
31. Bulte J.W., Kraitchman D.L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004, 17:484-499.
32. Shapiro E.M., Skrtic S., Sharer K., Hill J.M., Dunbar C.E., Koretsky A.P. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A 2004, 101:10901-10906.
33. Hinds K.A., Hill J.M., Shapiro E.M., et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003, 102:867-872.
34. Oude Engberink R.D., van der Pol S.M., Dopp E.A., de Vries H.E., Blezer E.L. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 2007, 243:467-474.
35. Ahmed A.S., Leheta O., Younes S. In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates. Blood Transfus 2010, 8:28-35.
36. Skripchenko A., Kurtz J., Moroff G., Wagner S.J. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Transfusion 2008, 48:1469-1477.
37. Li Z.Y., Delaney M.K., O'Brien K.A., Du X.P. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010, 30:2341-2349.
38. Chertok B., David A.E., Moffat B.A., Yang V.C. Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. Biomaterials 2009, 30:6780-6787.